Spanish Grifols procures plasma assets from Green Cross for $460m | FI SENSE


Spanish pharmaceutical company Grifols announced it has acquired plasma assets in North America for $460 million.

Grifols will buy a plasma fractionation plant in Canada and two purification facilities and 11 plasma collection centres in the United States, the company said in a statement.The Barcelona-based firm will need no new financing to carry out the acquisition, it said.

Grifols is one of the world’s top producers of treatments based on human plasma.



Leave a Reply

Your email address will not be published. Required fields are marked *

FI Sense